Pfizer Ltd. — Investor Relations & Filings
Pfizer Ltd. is a leading biopharmaceutical company focused on the discovery, development, and manufacture of innovative healthcare products. The company offers a diverse portfolio of medicines and vaccines across several therapeutic areas, including oncology, inflammation and immunology, rare diseases, internal medicine, and anti-infectives. Key products include advanced treatments for cardiovascular health, respiratory conditions, and various infectious diseases. Pfizer Ltd. leverages global research and development capabilities to provide high-quality, science-based solutions aimed at improving patient outcomes and addressing unmet medical needs. The company maintains a significant presence in the market through its commitment to scientific excellence and a robust pipeline of next-generation therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Delay/default in the payment of fines/penalties/dues etc. to authority | 2026-04-24 | English | |
| Reply to Clarification- Financial results | 2026-04-13 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-09 | English | |
| Copy of Newspaper Publication | 2026-04-08 | English | |
| Change in Management | 2026-03-31 | English | |
| Trading Window | 2026-03-28 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode Corporation
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
Pfizer Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60507/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60507 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60507 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60507 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60507}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pfizer Ltd. (id: 60507)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.